Social Media Platforms: a Direct-to-Patient RWD Route

  • Patient focused care can only truly be supported with an empathetic perspective on patient experience.
  • RWD  is typically utilised in reviewing clinical endpoints, however, it could be used for patient reported outcomes, and this is vital to a more holistic view of the disease area and its impact.
  • Social media could be the gateway into this neglected evidence pool.

SVMPharma, driving the outcomes that matter with RWE studies that lead to positive HTA submissions and value based outcomes. Why be limited with small study populations when SVMPharma are able to deliver study outcomes of over 1000 patients?

Click here to read the source article

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit and contact us at